6-152256617-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182961.4(SYNE1):​c.19104+17A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0643 in 1,612,740 control chromosomes in the GnomAD database, including 3,916 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.061 ( 319 hom., cov: 32)
Exomes 𝑓: 0.065 ( 3597 hom. )

Consequence

SYNE1
NM_182961.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.41

Publications

6 publications found
Variant links:
Genes affected
SYNE1 (HGNC:17089): (spectrin repeat containing nuclear envelope protein 1) This gene encodes a spectrin repeat containing protein expressed in skeletal and smooth muscle, and peripheral blood lymphocytes, that localizes to the nuclear membrane. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia 8, also referred to as autosomal recessive cerebellar ataxia type 1 or recessive ataxia of Beauce. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
SYNE1 Gene-Disease associations (from GenCC):
  • autosomal recessive ataxia, Beauce type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • arthrogryposis multiplex congenita 3, myogenic type
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Emery-Dreifuss muscular dystrophy 4, autosomal dominant
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive myogenic arthrogryposis multiplex congenita
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 6-152256617-T-C is Benign according to our data. Variant chr6-152256617-T-C is described in ClinVar as Benign. ClinVar VariationId is 262175.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.118 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE1NM_182961.4 linkc.19104+17A>G intron_variant Intron 102 of 145 ENST00000367255.10 NP_892006.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE1ENST00000367255.10 linkc.19104+17A>G intron_variant Intron 102 of 145 1 NM_182961.4 ENSP00000356224.5 Q8NF91-1

Frequencies

GnomAD3 genomes
AF:
0.0606
AC:
9214
AN:
152080
Hom.:
319
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0617
Gnomad AMI
AF:
0.0329
Gnomad AMR
AF:
0.0467
Gnomad ASJ
AF:
0.124
Gnomad EAS
AF:
0.126
Gnomad SAS
AF:
0.114
Gnomad FIN
AF:
0.0193
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0572
Gnomad OTH
AF:
0.0717
GnomAD2 exomes
AF:
0.0680
AC:
17087
AN:
251346
AF XY:
0.0723
show subpopulations
Gnomad AFR exome
AF:
0.0610
Gnomad AMR exome
AF:
0.0331
Gnomad ASJ exome
AF:
0.112
Gnomad EAS exome
AF:
0.122
Gnomad FIN exome
AF:
0.0218
Gnomad NFE exome
AF:
0.0595
Gnomad OTH exome
AF:
0.0761
GnomAD4 exome
AF:
0.0647
AC:
94476
AN:
1460542
Hom.:
3597
Cov.:
31
AF XY:
0.0671
AC XY:
48777
AN XY:
726554
show subpopulations
African (AFR)
AF:
0.0591
AC:
1976
AN:
33452
American (AMR)
AF:
0.0356
AC:
1592
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.113
AC:
2952
AN:
26078
East Asian (EAS)
AF:
0.137
AC:
5442
AN:
39638
South Asian (SAS)
AF:
0.128
AC:
11042
AN:
86204
European-Finnish (FIN)
AF:
0.0226
AC:
1202
AN:
53204
Middle Eastern (MID)
AF:
0.122
AC:
703
AN:
5758
European-Non Finnish (NFE)
AF:
0.0585
AC:
64977
AN:
1111196
Other (OTH)
AF:
0.0761
AC:
4590
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
5000
9999
14999
19998
24998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2586
5172
7758
10344
12930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0606
AC:
9220
AN:
152198
Hom.:
319
Cov.:
32
AF XY:
0.0607
AC XY:
4520
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.0616
AC:
2556
AN:
41518
American (AMR)
AF:
0.0466
AC:
713
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
432
AN:
3470
East Asian (EAS)
AF:
0.126
AC:
653
AN:
5172
South Asian (SAS)
AF:
0.115
AC:
556
AN:
4814
European-Finnish (FIN)
AF:
0.0193
AC:
205
AN:
10620
Middle Eastern (MID)
AF:
0.0986
AC:
29
AN:
294
European-Non Finnish (NFE)
AF:
0.0573
AC:
3893
AN:
67996
Other (OTH)
AF:
0.0724
AC:
153
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
423
846
1270
1693
2116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
112
224
336
448
560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0632
Hom.:
366
Bravo
AF:
0.0634
Asia WGS
AF:
0.114
AC:
396
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Autosomal recessive ataxia, Beauce type;C2751807:Emery-Dreifuss muscular dystrophy 4, autosomal dominant Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.086
DANN
Benign
0.34
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17082389; hg19: chr6-152577752; COSMIC: COSV54935033; API